Status:

COMPLETED

Nimotuzumab in Adults With Glioblastoma Multiforma

Lead Sponsor:

Oncoscience AG

Collaborating Sponsors:

Neurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany

University of Bonn

Conditions:

Adults With Glioblastoma Multiforma

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

Determination of efficiency of nimotuzumab in adults with glioblastoma multiforma

Detailed Description

The objective of the present study is a comparison of treatment of patients with newly diagnosed glioblastoma multiforme grade IV. Patients will be randomized in one of two arms when included. Patient...

Eligibility Criteria

Inclusion

  • Patient signed informed consent
  • Newly diagnosed, histologically confirmed glioblastoma multiforme grade IV
  • Condition is measurable by MRI in at least one dimension
  • Age 18-70
  • Karnofsky-Index \> 40
  • Treatment in a study center
  • Female patients with a childbearing potential must have a negative pregnancy test within one week before inclusion in the trial. Those female and male patients admitted in the study must use a reliable method of contraception.
  • Adequate haematological, renal and hepatic function:
  • Leucocytes \>2.0x10\^9/l
  • Hb\> 10g/dl
  • Billirubin total \< 2.5x upper limit of normal (ULN)
  • Creatinin i.S. \< 1.5x ULN
  • AST (GOT)/ALT (GPT) \< 5x ULN

Exclusion

  • Patients with history of anaphylactic reaction to murine or humanized antibody
  • Patients with evidence second malignancy
  • Patients who are pregnant or patients who refused adequate contraceptive precaution (female and male) during the trial
  • Pregnancy and lactation
  • Other conditions considered by investigators as sound reasons for disqualification from enrolment into the study such as: potential non compliance with protocol requirement
  • No MRI for tumour evaluation

Key Trial Info

Start Date :

August 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2012

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00753246

Start Date

August 1 2007

End Date

January 1 2012

Last Update

December 3 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dep. Neurosurgery, Univ. Hamburg

Hamburg, Germany, 20246